• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶逆转录酶(TERT)启动子突变型癌症的永生机制具有自我强化性且是可逆的。

The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.

作者信息

Stevers Nicholas O, Kim Somang, Yuan Jimmy Bo, Barger Carter J, Hong Chibo, Lenzo Olivia, McKinney Andrew M, Wu Samuel H, Lee Yu Jin, Kwok Darwin W, Suwala Abigail K, Appin Christina L, Gordan John D, Molinaro Annette M, Song Jun S, Costello Joseph F

机构信息

Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.

Department of Physics, University of Illinois, Urbana-Champaign, Champaign, IL, USA; Institute for Genomic Biology, University of Illinois, Urbana-Champaign, Champaign, IL, USA; Cancer Center at Illinois, University of Illinois, Urbana-Champaign, Champaign, IL, USA.

出版信息

Mol Cell. 2025 Jun 19;85(12):2337-2354.e9. doi: 10.1016/j.molcel.2025.05.026. Epub 2025 Jun 12.

DOI:10.1016/j.molcel.2025.05.026
PMID:40513567
Abstract

Activating mutations in the telomerase reverse transcriptase (TERT) promoter are prevalent in cancer and enable limitless cell division characteristic of immortal cells. Solving the immortality mechanism represents a major step toward selective reversal in cancer cells. TERT promoter (TERTp) mutations create a de novo E26 transformation-specific (ETS) transcription factor binding motif. Here, we analyzed 53 cell lines representing 16 cancer types and 6 recurrent TERTp mutations and found that the GA-binding protein (GABP) tetramer is responsible for promoter activation in all cases. Surprisingly, TERT expression is maintained after tetramer depletion. Further investigation revealed an underlying network of auto-suppression among the GABP subunits. Release from it drives TERT maintenance via upregulated GABP dimers or a paralogous tetramer. The GABPB1L tetramer is therefore a pan-cancer, pan-mutation activator of the mutant TERT promoter, but it is replaceable. Domains shared by the three GABP complexes, rather than solely the B1L tetramer, are mutation-specific vulnerabilities.

摘要

端粒酶逆转录酶(TERT)启动子中的激活突变在癌症中普遍存在,并能实现永生化细胞特有的无限细胞分裂。解决永生机制是癌细胞选择性逆转的重要一步。TERT启动子(TERTp)突变产生了一个全新的E26转化特异性(ETS)转录因子结合基序。在此,我们分析了代表16种癌症类型的53个细胞系和6种常见的TERTp突变,发现GA结合蛋白(GABP)四聚体在所有情况下都负责启动子激活。令人惊讶的是,四聚体耗尽后TERT表达仍得以维持。进一步研究揭示了GABP亚基之间存在自动抑制的潜在网络。从该网络中释放出来可通过上调的GABP二聚体或同源四聚体驱动TERT维持。因此,GABPB1L四聚体是突变型TERT启动子的一种泛癌、泛突变激活剂,但它是可替代的。三种GABP复合物共有的结构域,而非仅B1L四聚体,是突变特异性的脆弱点。

相似文献

1
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.端粒酶逆转录酶(TERT)启动子突变型癌症的永生机制具有自我强化性且是可逆的。
Mol Cell. 2025 Jun 19;85(12):2337-2354.e9. doi: 10.1016/j.molcel.2025.05.026. Epub 2025 Jun 12.
2
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.β1L 异构体的 GABP 破坏以 TERT 启动子突变依赖性方式逆转胶质母细胞瘤复制性永生。
Cancer Cell. 2018 Sep 10;34(3):513-528.e8. doi: 10.1016/j.ccell.2018.08.003.
3
An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.一项关于TERT启动子复发性突变时转录因子结合的相互作用蛋白质组学研究。
Proteomics. 2016 Feb;16(3):417-26. doi: 10.1002/pmic.201500327. Epub 2016 Jan 8.
4
Cancer-specific loss of activation sensitizes glioblastoma to DNA damage.抑癌基因 失活使胶质母细胞瘤对 DNA 损伤敏感
Proc Natl Acad Sci U S A. 2021 Mar 30;118(13). doi: 10.1073/pnas.2008772118.
5
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.癌症。转录因子GABP在癌症中选择性地结合并激活突变的端粒酶逆转录酶(TERT)启动子。
Science. 2015 May 29;348(6238):1036-9. doi: 10.1126/science.aab0015. Epub 2015 May 14.
6
TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.端粒酶反转录酶启动子突变与 GABP 转录因子在肿瘤发生中的作用:是敌是友尚未可知。
Cancer Lett. 2020 Nov 28;493:1-9. doi: 10.1016/j.canlet.2020.07.003. Epub 2020 Aug 6.
7
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers.人类癌症中沉默的端粒酶逆转录酶(TERT)等位基因普遍存在启动子高甲基化现象。
Cell Oncol (Dordr). 2020 Oct;43(5):847-861. doi: 10.1007/s13402-020-00531-7. Epub 2020 May 28.
8
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.GABP 将致癌基因信号与 TERT 启动子突变型癌症中的端粒调控偶联。
Cell Rep. 2022 Sep 20;40(12):111344. doi: 10.1016/j.celrep.2022.111344.
9
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.TERT 启动子热点突变及其与头颈鳞癌患者 TERT 水平和端粒侵蚀的关系。
J Cancer Res Clin Oncol. 2020 Feb;146(2):381-389. doi: 10.1007/s00432-020-03130-z. Epub 2020 Jan 20.
10
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.端粒酶抑制是低肿瘤体积 TERT 启动子突变型神经胶质瘤模型的有效治疗策略。
Neuro Oncol. 2023 Jul 6;25(7):1275-1285. doi: 10.1093/neuonc/noad024.

本文引用的文献

1
Mechanistic basis of atypical TERT promoter mutations.非典型 TERT 启动子突变的机制基础。
Nat Commun. 2024 Nov 18;15(1):9965. doi: 10.1038/s41467-024-54158-5.
2
Fructose-1,6-bisphosphatase 1 dephosphorylates and inhibits TERT for tumor suppression.果糖-1,6-二磷酸酶 1 去磷酸化并抑制 TERT 以抑制肿瘤。
Nat Chem Biol. 2024 Nov;20(11):1505-1513. doi: 10.1038/s41589-024-01597-2. Epub 2024 Mar 27.
3
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
全肿瘤分析揭示了 TERT 启动子突变的早期起源和 TERT 表达的细胞间异质性。
Neuro Oncol. 2024 Apr 5;26(4):640-652. doi: 10.1093/neuonc/noad231.
4
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume.端粒酶抑制是低肿瘤体积 TERT 启动子突变型神经胶质瘤模型的有效治疗策略。
Neuro Oncol. 2023 Jul 6;25(7):1275-1285. doi: 10.1093/neuonc/noad024.
5
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas.精氨酸琥珀酸裂解酶驱动胶质母细胞瘤中突变型端粒酶逆转录酶启动子的激活。
Mol Cell. 2022 Dec 1;82(23):4582-4583. doi: 10.1016/j.molcel.2022.11.009.
6
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer.GABP 将致癌基因信号与 TERT 启动子突变型癌症中的端粒调控偶联。
Cell Rep. 2022 Sep 20;40(12):111344. doi: 10.1016/j.celrep.2022.111344.
7
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer.TERT 启动子重复序列的保守特征揭示了一种激活机制,该机制模拟了癌症中的热点突变。
Nat Commun. 2022 Sep 16;13(1):5430. doi: 10.1038/s41467-022-33099-x.
8
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients.2092 例甲状腺癌患者真实世界分析中 TERT 启动子突变的频率。
Endocrinol Metab (Seoul). 2022 Aug;37(4):652-663. doi: 10.3803/EnM.2022.1477. Epub 2022 Jul 22.
9
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.靶向端粒:端粒维持机制特异性癌症治疗的进展。
Nat Rev Cancer. 2022 Sep;22(9):515-532. doi: 10.1038/s41568-022-00490-1. Epub 2022 Jul 5.
10
TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.神经祖细胞中的 TERT 启动子 C228T 突变赋予了体内端粒缩短后的生长优势。
Neuro Oncol. 2022 Dec 1;24(12):2063-2075. doi: 10.1093/neuonc/noac080.